-
1
-
-
0029898079
-
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis
-
BANNWARTH B, PEHOURCQ F, SCHAEVERBEKE T, DEHAIS J: Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 1996; 30: 194-210.
-
(1996)
Clin Pharmacokinet
, vol.30
, pp. 194-210
-
-
Bannwarth, B.1
Pehourcq, F.2
Schaeverbeke, T.3
Dehais, J.4
-
2
-
-
44949171918
-
-
MEDAC [updated 2007; cited 12-29-2008]; Available from
-
MEDAC: Summary of Product Characteristics for Metoject. 2007 [updated 2007; cited 12-29-2008]; Available from: http://www.lakemedelsverket.se/upload/ SPC-PIL/Pdf/enhumspc/Metoject%20sol%20for%20inj%20pre-filled%20syringe%20ENG. pdf.
-
(2007)
Summary of Product Characteristics for Metoject
-
-
-
3
-
-
0032736894
-
The effects of methotrexate on pregnancy, fertility and lactation
-
LLOYD ME, CARR M, MCELHATTON P et al.: The effects of methotrexate on pregnancy, fertility and lactation. QJM 1999; 92: 551-563 (Pubitemid 29501961)
-
(1999)
QJM - Monthly Journal of the Association of Physicians
, vol.92
, Issue.10
, pp. 551-563
-
-
Lloyd, M.E.1
Carr, M.2
McElhatton, P.3
Hall, G.M.4
Hughes, R.A.5
-
4
-
-
0030968122
-
Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother
-
May
-
BUCKLEY LM, BULLABOY CA, LEICHTMAN L, MARQUEZ M: Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997 May; 40: 971-973
-
(1997)
Arthritis Rheum
, vol.40
, pp. 971-973
-
-
Buckley, L.M.1
Bullaboy, C.A.2
Leichtman, L.3
Marquez, M.4
-
5
-
-
0029135404
-
Methotrexate and misoprostol to terminate early pregnancy
-
HAUSKNECHT RU: Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995; 333: 537-540
-
(1995)
N Engl J Med
, vol.333
, pp. 537-540
-
-
Hausknecht, R.U.1
-
7
-
-
67650115788
-
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
-
Nov 25.
-
VISSER K, KATCHAMART W, LOZA E et al.: Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2008 Nov 25.
-
(2008)
Ann Rheum Dis
-
-
Visser, K.1
Katchamart, W.2
Loza, E.3
-
9
-
-
0037309462
-
The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes
-
Feb
-
CHAKRAVARTY EF, SANCHEZ-YAMAMOTO D, BUSH TM: The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003 Feb; 30: 241-246
-
(2003)
J Rheumatol
, vol.30
, pp. 241-246
-
-
Chakravarty, E.F.1
Sanchez-Yamamoto, D.2
Bush, T.M.3
-
10
-
-
0028217035
-
Methotrexate exposure prior to and during pregnancy
-
DONNENFELD AE, PASTUSZAK A, NOAH JS, SCHICK B, ROSE NC, KOREN G: Methotrexate exposure prior to and during pregnancy. Teratology 1994; 49: 79-81.
-
(1994)
Teratology
, vol.49
, pp. 79-81
-
-
Donnenfeld, A.E.1
Pastuszak, A.2
Noah, J.S.3
Schick, B.4
Rose, N.C.5
Koren, G.6
-
11
-
-
34250201534
-
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease
-
OSTENSEN M, VON ESEBECK M, VILLIGER PM:Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol 2007; 34: 1266-1269
-
(2007)
J Rheumatol
, vol.34
, pp. 1266-1269
-
-
Ostensen, M.1
Von Esebeck, M.2
Villiger, P.M.3
-
12
-
-
0025315423
-
Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease
-
KOZLOWSKI RD, STEINBRUNNER JV, MACKENZIE AH, CLOUGH JD, WILKE WS, SEGAL AM: Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990; 88: 589-92.
-
(1990)
Am J Med
, vol.88
, pp. 589-592
-
-
Kozlowski, R.D.1
Steinbrunner, J.V.2
MacKenzie, A.H.3
Clough, J.D.4
Wilke, W.S.5
Segal, A.M.6
-
13
-
-
0033848448
-
Low dose weekly methotrexate in early pregnancy. A case series and review of the literature
-
OSTENSEN M, HARTMANN H, SALVESEN K: Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000; 27: 1872-1875
-
(2000)
J Rheumatol
, vol.27
, pp. 1872-1875
-
-
Ostensen, M.1
Hartmann, H.2
Salvesen, K.3
-
14
-
-
10044253361
-
Low dose methotrexate in the first trimester of pregnancy: Results of a French collaborative study
-
LEWDEN B, VIAL T, ELEFANT E, NELVA A, CARLIER P, DESCOTES J: Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. J Rheumatol 2004; 31: 2360-2365
-
(2004)
J Rheumatol
, vol.31
, pp. 2360-2365
-
-
Lewden, B.1
Vial, T.2
Elefant, E.3
Nelva, A.4
Carlier, P.5
Descotes, J.6
-
17
-
-
33748559091
-
Human pregnancy safety for agents used to treat rheumatoid arthritis: Adequacy of available information and strategies for developing post-marketing data
-
CHAMBERS CD, TUTUNCU ZN, JOHNSON D, JONES KL: Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 2006; 8: 215.
-
(2006)
Arthritis Res Ther
, vol.8
, pp. 215
-
-
Chambers, C.D.1
Tutuncu, Z.N.2
Johnson, D.3
Jones, K.L.4
-
19
-
-
0037532941
-
Effect of methotrexate on male fertility
-
FRENCH AE, KOREN G: Effect of methotrexate on male fertility. Can Fam Physician 2003; 49: 577-578
-
(2003)
Can Fam Physician
, vol.49
, pp. 577-578
-
-
French, A.E.1
Koren, G.2
|